COVID-19 Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D0RG9A
|
|||
Drug Name |
Monensin sodium
|
|||
Synonyms |
AKOS025147337; AM84797; C36H61NaO11; CAS-22373-78-0; CCG-220748; CHEMBL1908308; CS-0007881; DSSTox_CID_25573; DSSTox_GSID_45573; DSSTox_RID_80970; DTXSID2045573; HMS2097E18; HMS3714E18; HY-N0150; MLS002153986; Monensin A sodium salt; Monensin sodium salt; NCGC00017089-01; NSC343257; SMR001233320; Sodium monensin; Tox21_110771; Tox21_113191; XOIQMTLWECTKJL-FBZUZRIGSA-M; s2324
|
|||
Drug Type |
Small molecular drug
|
|||
Indication | Middle East Respiratory Syndrome (MERS) | Investigative | [1] | |
Therapeutic Class |
Antiviral Agents
|
|||
Structure |
Download2D MOL |
|||
Formula |
C36H61NaO11
|
|||
Canonical SMILES |
CCC1(CCC(O1)C2(CCC3(O2)CC(C(C(O3)C(C)C(C(C)C(=O)[O-])OC)C)O)C)C4C(CC(O4)C5C(CC(C(O5)(CO)O)C)C)C.[Na+]
|
|||
InChI |
1S/C36H62O11.Na/c1-10-34(31-20(3)16-26(43-31)28-19(2)15-21(4)36(41,18-37)46-28)12-11-27(44-34)33(8)13-14-35(47-33)17-25(38)22(5)30(45-35)23(6)29(42-9)24(7)32(39)40;/h19-31,37-38,41H,10-18H2,1-9H3,(H,39,40);/q;+1/p-1/t19-,20-,21+,22+,23-,24-,25-,26+,27+,28-,29+,30-,31+,33-,34-,35+,36-;/m0./s1
|
|||
InChIKey |
XOIQMTLWECTKJL-FBZUZRIGSA-M
|
|||
CAS Number |
CAS 22373-78-0
|
|||
PubChem Compound ID |
References | Top | |||
---|---|---|---|---|
1 | High-Throughput Screening and Identification of Potent Broad-Spectrum Inhibitors of Coronaviruses. J Virol. 2019 May 29;93(12). pii: e00023-19. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.